MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphoma

Regulation of IL-17 in Human CCR6+ Effector Memory T Cells

(2014) H. Liu et al.   JOURNAL OF IMMUNOLOGY

Interleukin 22 Signaling Promotes Cell Growth in Mantle Cell Lymphoma

(2014) Pascal Gelebart et al.   Translational Oncology

Role of microRNA in the pathogenesis of malignant lymphoma

(2013) Hiroyuki Tagawa et al.   CANCER SCIENCE

Small nucleolar RNA expression profiling identifies potential prognostic markers in peripheral T-cell lymphoma

(2012) W. Valleron et al.   BLOOD

Blockade of miR-150 Maturation by MLL-Fusion/MYC/LIN-28 Is Required for MLL-Associated Leukemia

(2012) Xi Jiang et al.   CANCER CELL

Deep-Sequencing Analysis Reveals that the miR-199a2/214 Cluster within DNM3os Represents the Vast Majority of Aberrantly Expressed MicroRNAs in Sézary Syndrome

(2012) Yongjun Qin et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Expression of chemokine receptors on circulating tumor cells in patients with solid tumors

(2012) Alberto Fusi et al.   Journal of Translational Medicine

Overexpression of CCL20 and its receptor CCR6 predicts poor clinical prognosis in human gliomas

(2012) Liang Wang et al.   MEDICAL ONCOLOGY

MiR-29a down-regulation in ALK-positive anaplastic large cell lymphomas contributes to apoptosis blockade through MCL-1 overexpression

(2011) C. Desjobert et al.   BLOOD

Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150

(2011) M. Ghisi et al.   BLOOD

Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)

(2011) U. Ralfkiaer et al.   BLOOD

IL-22, but Not IL-17, Dominant Environment in Cutaneous T-cell Lymphoma

(2011) T. Miyagaki et al.   CLINICAL CANCER RESEARCH

T Lymphocyte Recruitment into Renal Cell Carcinoma Tissue: A Role for Chemokine Receptors CXCR3, CXCR6, CCR5, and CCR6

(2011) Kimberley A. Oldham et al.   EUROPEAN UROLOGY

The role of microRNA-150 as a tumor suppressor in malignant lymphoma

(2011) A Watanabe et al.   LEUKEMIA

miRNA expression profiling of mycosis fungoides

(2011) Marloes S. van Kester et al.   Molecular Oncology

Involvement of CCR6/CCL20/IL-17 Axis in NSCLC Disease Progression

(2011) Sophie Kirshberg et al.   PLoS One

MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential

(2010) E. Ballabio et al.   BLOOD

The DLEU2/miR-15a/16-1 Cluster Controls B Cell Proliferation and Its Deletion Leads to Chronic Lymphocytic Leukemia

(2010) Ulf Klein et al.   CANCER CELL

Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia

(2009) Y. Yamanaka et al.   BLOOD

The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer

(2009) Pirus Ghadjar et al.   INTERNATIONAL JOURNAL OF CANCER

Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling

(2009) Stefanie Eyerich et al.   JOURNAL OF CLINICAL INVESTIGATION

MicroRNAs in Cancer: Small Molecules With a Huge Impact

(2009) Marilena V. Iorio et al.   JOURNAL OF CLINICAL ONCOLOGY

Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis Pathogenesis

(2009) Erin G. Harper et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from TH-17, TH1 and TH2 cells

(2009) Sara Trifari et al.   NATURE IMMUNOLOGY

Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells

(2009) Thomas Duhen et al.   NATURE IMMUNOLOGY

Causes and consequences of microRNA dysregulation in cancer

(2009) Carlo M. Croce   NATURE REVIEWS GENETICS

MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes

(2008) M. Inomata et al.   BLOOD

Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphoma

(2008) J Dien Bard et al.   LEUKEMIA